1
|
Avezum A, Cordeiro Mattos A, Oliveira GBF, Pinto IM, Rombaldi AR, Fonseca HAR, Bocchese JI, Saback G, Taborga PRC, Silva TO, Campoa RN, Ferreira MHB, Savioli Neto F, Magalhaes CC, Saraiva JFK. P6368Blood pressure control in a registry of clinical practice, PINNACLE-BRAZIL REGISTRY. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Abstract
Abstract
Introduction
The prevalence of hypertension is estimated to be nearly 50% among Brazilian adults. Achieving an adequate control of this CVD risk factor is challenging but truly relevant on a public health perspective, as this is the top-ranking cause of all deaths globally.
Purpose
We aimed to describe crude and simple metrics of blood pressure management (including its control), as based on current guideline-derived recommendations, after one year of the clinical practice registry
Methods
Patients with documented Hypertension were included by using electronic case report form based on the ACC PINNACLE Registry. The registry has been enrolling patients from general practitioners and specialists. The main goal of the PINNACLE program is to improve the quality of care in “real world” clinical practice. Patients data were evaluated after 01 year of follow-up on regular clinical appointments and the differences on clinical practice were evaluated
Results
Currently, PINNACLE-Brazil has enrolled 7598 patients, with 87% of diagnosed hypertension. Percentage of patients with a diagnosis of hypertension who had a blood pressure measurement <140/90 mmHg was 47.9% (baseline) and 57.3% (follow-up). Percentage of patients who had a blood pressure <140/90 mm Hg, or who had a blood pressure ≥140/90 mm Hg and were prescribed ≥2 antihypertensive medications were 67.1% on baseline and 71.2% after 1 year.
Conclusion
The preliminary data of PINNACLE Registry in Brazil shows that a significant proportion of hypertensive patients (nearly half) have not presented with adequate control of blood pressure levels and, moreover, a large proportion have not been treated with recommended combination of 02 or more antihypertensive medications to reach targeted BP levels the quality of care was improving after 01 year of registry.
Acknowledgement/Funding
ACC Foundation
Collapse
Affiliation(s)
- A Avezum
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | | | - G B F Oliveira
- Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
| | - I M Pinto
- Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
| | - A R Rombaldi
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - H A R Fonseca
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - J I Bocchese
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - G Saback
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - P R C Taborga
- Clinica de Especialidades GLOBALMED, Sao PAulo, Brazil
| | - T O Silva
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - R N Campoa
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - M H B Ferreira
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - F Savioli Neto
- Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
| | - C C Magalhaes
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - J F K Saraiva
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| |
Collapse
|
2
|
Saraiva JFK, Cordeiro Mattos A, Saraiva GBF, Pinto IM, Rombaldi AR, Kato NH, Gomes Da Silva LF, Minelli C, Carvalho ITN, Dantas JMM, De Souza Filho JM, Figuinha FCR, Segre CAW, Fonseca HAR, Avezum A. P6444Cardiovascular secondary prevention setting and lipid controlu, update data from PINNACLE BRAZIL REGISTRY. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.1038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Lipid control is highly effective and improves clinical outcomes in coronary artery disease (CAD) patients, thus is one of the pillars of the cardiovascular secondary prevention.
Purpose
The aim of this preliminary analysis was to describe the lipid management in CAD patients in Brazil after one year of the clinical practice registry.
Methods
Patients with documented CAD were included by using electronic case report form based on the ACC PINNACLE Registry. The registry has been enrolling patients from general practitioners and specialists. Patients data were evaluated after 01 year of follow-up on regular clinical appointments and the differences on clinical practice were evaluated
Results
Currently, PINNACLE-Brazil enrolled individuals, with 2234 (29.4%) patients with CAD. Prescription of statin therapy was identified in 85.6% baseline and 78.3% follow-up. CAD patients with LDL-c <100 mg/dL were 47.3% baseline and 38.5% follow-up and at least one lipid profile assessment occurred in 60.9% baseline and 51.2% follow-up. CAD patients who have an LDL-c result <100 mg/dL, or >100 mg/dL with a documented plan to achieve LDL-c <100 mg/dL, were 48.1% (baseline) and 38.5% (follow-up).
Conclusion
The preliminary results of PINNACLE-Brazil show that, despite the relatively high prescription rate of statin therapy, LDL-c targeted level for CVD secondary prevention has not been achieved in the majority of patients after 01 year of follow-up. Nationwide knowledge translation initiatives are needed to improve the CVD burden in Brazil
Acknowledgement/Funding
ACC Foundation
Collapse
Affiliation(s)
- J F K Saraiva
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | | | - G B F Saraiva
- Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
| | - I M Pinto
- Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
| | - A R Rombaldi
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - N H Kato
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | | | - C Minelli
- Hospital Matão, Ribeirão Preto, Brazil
| | - I T N Carvalho
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - J M M Dantas
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | | | - F C R Figuinha
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - C A W Segre
- Instituto do Coracao FMUSP, Sao Paulo, Brazil
| | - H A R Fonseca
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| | - A Avezum
- Cardiology Society of Sao Paulo (SOCESP), Sao Paulo, Brazil
| |
Collapse
|
3
|
Izar MC, Fonzar WT, Silva TP, Franca CN, Fonseca HAR, Teixeira D, Maugeri IML, Coste MER, Bianco HT, Pesquero JB, Rodrigues AAE, Carvalho ACC, Fonseca FAH. P5388Role of the immune-inflammatory biomarkers and atherosclerosis development in subjects with familial hypercholesterolemia. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M C Izar
- Federal University of Sao Paulo, Sao Paulo, Brazil
| | - W T Fonzar
- Federal University of Sao Paulo, Sao Paulo, Brazil
| | - T P Silva
- Federal University of Sao Paulo, Sao Paulo, Brazil
| | - C N Franca
- Federal University of Sao Paulo, Sao Paulo, Brazil
| | | | - D Teixeira
- Federal University of Sao Paulo, Sao Paulo, Brazil
| | | | - M E R Coste
- Federal University of Sao Paulo, Sao Paulo, Brazil
| | - H T Bianco
- Federal University of Sao Paulo, Sao Paulo, Brazil
| | - J B Pesquero
- Federal University of Sao Paulo, Sao Paulo, Brazil
| | | | | | | |
Collapse
|